Following validation by a number of independent groups worldwide, in studies involving more than 8,000 patients, the American Society of Clinical Oncology has recommended the test as standard for all newly diagnosed breast cancer patients. The test is not currently available in Ireland, but its developers hope that funding will be made available for its implementation in Ireland in the near future.
By measuring the levels of a particular enzyme in the tumour, the new enzyme test can predict whether the patient’s cancer will spread beyond the breast site or not. If the levels of the enzyme – known as uPA – are found to be high, there is a stronger likelihood of the patient developing ‘secondaries’ or metastasis. This means that the patient would require chemotherapy as well as surgery to fight the disease. However, if the levels of uPA are found to be low, a combination of surgery and radiotherapy may be sufficient in order to address the cancer, helping to minimise the expense and the discomfort of the treatment for the patient.
“At the moment most women undergo long and uncomfortable sessions of chemotherapy after their initial breast surgery, but this new enzyme test can help to offer a more tailored solution for patients,” explains Professor Joe Duffy from the UCD Conway Institute, University College Dublin and St Vincent’s University Hospital, Dublin, Ireland, who led the team of scientists and doctors who developed the test. “This new test may help some women newly diagnosed with breast cancer avoid chemotherapy. It leans towards the concept of personalised treatment rather than giving the chemotherapy blunderbuss to all patients, regardless of whether it is suitable for them or not.”
Breast cancer is one of the most common cancers affecting women in Ireland, second only to non-melanoma skin cancer. As the Irish population ages, it is predicted that numbers of new cases of breast cancer will continue to rise and so the development of this test will be a significant breakthrough for many women.
Dominic Martella | alfa
NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases
Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.
Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...
16.03.2018 | Event News
13.03.2018 | Event News
08.03.2018 | Event News
19.03.2018 | Trade Fair News
19.03.2018 | Life Sciences
19.03.2018 | Life Sciences